Andreessen Horowitz leads Series B round for Omada Health
Digital therapeutics firm Omada Health said Wednesday that it has raised $23 million in Series B financing. Andreessen Horowitz led the round with participation from Kaiser Permanente Ventures and previous backers that include U.S. Venture Partners and The Vertical Group. Also, Balaji S. Srinivasan, a general partner at Andreessen Horowitz, has been added to Omada Health’s board of directors.
9 April 2014•4 mins read
